Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms

J Kirchmair, MJ Williamson, JD Tyzack… - Journal of chemical …, 2012 - ACS Publications
Metabolism of xenobiotics remains a central challenge for the discovery and development of
drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations …

Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2

SF Zhou, B Wang, LP Yang, JP Liu - Drug metabolism reviews, 2010 - Taylor & Francis
Human CYP1A2 is one of the major CYPs in human liver and metabolizes a number of
clinical drugs (eg, clozapine, tacrine, tizanidine, and theophylline; n> 110), a number of …

Generation of a set of simple, interpretable ADMET rules of thumb

MP Gleeson - Journal of medicinal chemistry, 2008 - ACS Publications
A set of simple, consistent structure–property guides have been determined from an analysis
of a number of key ADMET assays run within GSK: solubility, permeability, bioavailability …

Electrochemical γ-selective deuteration of pyridines

L Shi, M Liu, L Zheng, Q Gao, M Wang, X Wang… - Organic …, 2024 - ACS Publications
Herein, we first report a γ-selective deuteration reaction of pyridines via H/D exchange
without the need for preinstalled directing groups and transformable functional groups. The …

Computational prediction of cytochrome P450 inhibition and induction

H Kato - Drug metabolism and pharmacokinetics, 2020 - Elsevier
Cytochrome P450 (CYP) enzymes play an important role in the phase I metabolism of many
xenobiotics. Most drug–drug interactions (DDIs) associated with CYP are caused by either …

[HTML][HTML] Descriptors of cytochrome inhibitors and useful machine learning based methods for the design of safer drugs

TC Beck, KR Beck, J Morningstar, MM Benjamin… - Pharmaceuticals, 2021 - mdpi.com
Roughly 2.8% of annual hospitalizations are a result of adverse drug interactions in the
United States, representing more than 245,000 hospitalizations. Drug–drug interactions …

Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development

B Wang, SF Zhou - Current medicinal chemistry, 2009 - benthamdirect.com
Human cytochrome P450 1A2 (CYP1A2) is one of the major CYPs in the liver (&sim13%)
and metabolizes about 20% of clinically used drugs. CYP1A2 is a 515-residue protein with a …

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes

H Raunio, M Kuusisto, RO Juvonen… - Frontiers in …, 2015 - frontiersin.org
The adverse effects to humans and environment of only few chemicals are well known.
Absorption, distribution, metabolism, and excretion (ADME) are the steps of pharmaco …

Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects

Y Li, J Ning, Y Wang, C Wang, C Sun, X Huo, Z Yu… - Toxicology Letters, 2018 - Elsevier
The high risk of herb-drug interactions (HDIs) mediated by the herbal medicines and dietary
supplements which containing abundant flavonoids had become more and more frequent in …

Artificial intelligence in synthetic chemistry: achievements and prospects

II Baskin, TI Madzhidov, IS Antipin… - Russian Chemical …, 2017 - iopscience.iop.org
The review is devoted to the achievements in analysis of information on chemical reactions
using machine learning methods. Four large areas that actively use these methods are …